Interview with Dr. Young-Ki Paik, President of the Human Proteome Organization (HUPO): Pharmacoproteomics and the approaching wave of "proteomics diagnostics"

Current Pharmacogenomics and Personalized Medicine

Volumn 7, Issue 4, 2009, Pages 243-248

  Paik, Y K ^a,b   Graham, J E ^c   Jones, M ^c   McDonald, F ^d   Holmes, C ^c   Ozdemir, V ^e  

^a Yonsei University   (South Korea)

^b Human Proteome Organization   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anticipatory governance; HUPO proteomics standards initiative; Innovation analysis; Personalized medicine; Pharmacoproteomics

Indexed keywords

BIOLOGICAL MARKER; PHEROMONE;

AGING; BIOCHEMISTRY; BIOINFORMATICS; BIOTECHNOLOGY; CAENORHABDITIS ELEGANS; CELL TYPE; CHEMICAL STRUCTURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GENETIC ANALYSIS; HEALTH CARE SYSTEM; HUMAN; HUMAN GENOME PROJECT; INDIVIDUALIZATION; INTERVIEW; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL RESEARCH; NEMATODE; NOTE; PATIENT CARE; PHARMACOGENOMICS; POSTDOCTORAL EDUCATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH KOREA; TISSUE TYPES; TWO DIMENSIONAL ELECTROPHORESIS;

CAENORHABDITIS ELEGANS;

EID: 73649088592     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569209790112292     Document Type: Note

References (18)

1. Singh OV, Vij N, Mogayzel PJ., Jr, et al. Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells. J Proteome Res 2006; 5(3): 562-71.
2. Kobayashi CA, Leite AL, Silva TL, et al. Proteomic analysis of kidney in rats chronically exposed to fluoride. Chem Biol Interact 2009; 180(2): 305-11.
3. Ignatenko NA, Yerushalmi HF, Pandey R, et al. Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047. Cancer Genomics Proteomics 2009; 6(3): 161-75.
4. Edvardsson N, Juul-Möller S, Omblus R, et al. Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation. J Intern Med 2003; 254(1): 95-101.
5. Kaveti S, Engen JR. Protein interactions probed with mass spectrometry. Methods Mol Biol 2006; 316: 179-97.
6. Wang Y, Dai Z, Sadee W, et al. A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. Mol Pharm 2006; 3(5): 566-78.
7. Anderson L, Anderson NG. High resolution twodimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA 1977; 74: 5421-5.
8. Anderson NG, Anderson NL. Twenty years of two-dimensional electrophoresis: past, present and future. Electrophoresis 1996; 17: 443-53.
9. Ozdemir V, Suarez-Kurtz G, Stenne R, et al. Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society. OMICS 2009; 13(1): 43-61.
10. Paik YK, Kim H, Lee EY, et al. Overview and introduction to clinical proteomics. Methods Mol Biol 2008; 428: 1-31.
11. Lee HJ, Lee EY, Kwon MS, et al. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr Opin Chem Biol 2006; 10(1): 42-9.
12. Na K, Lee EY, Lee HJ, et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for the hepatocellular carcinoma. Proteomics 2009; 9: 3989-99.
13. Butler GS, Dean RA, Tam EM, et al. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol Cell Biol 2008; 28(15): 4896-914.
14. Anonymous. Nature Editorial. Proteomics' new order. Nature 2005; 437: 169.
15. Orchard S, Deutsch EW, Binz PA, et al. Annual Spring Meeting of the Proteomics Standards Initiative. Proteomics 2009 Aug 10.
16. HUPO Proteomics Standards Initiative Developments. [Accessed October 14, 2009]. Available from: http://www.psidev.info.
17. Nedelkov D, Phillips DA, Tubbs KA, et al. Investigation of human protein variants and their frequency in the general population. Mol Cell Proteomics 2007; 6(7): 1183-7.
18. Service RF. Proteomics. Proteomics ponder prine time. Science 2008; 321: 1758-61.